BeStock  
Markets › Compare › NTLA vs DMRA

NTLA vs DMRA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
NTLA · Intellia Therapeutics$10.00 ▲ 5.04%
DMRA · Damora Therapeutics$23.22 ▼ 4.44%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

90123155188221Nov 24, '25May 26, '26Nov 20, '26
  • NTLA +19.8%
  • DMRA +42.4%

Head to head

MetricNTLADMRA
Price$10.00$23.22
Change today▲ 5.04%▼ 4.44%
Market cap$1.40B$1.44B
Return, 3 months-20.4%-23.4%
Return, year to date+11.2%+0.9%
Return, 1 year+21.8%+38.5%
P/E (TTM)–13.6
P/B2.33.9
P/E percentile vs own 5y78th99th
Dividend yield––
Revenue growth (YoY, latest qtr)-48.0%–
Net profit growth (YoY)-25.8%-921.1%
Gross margin––
Operating margin-821.2%–
Net margin-805.7%–
Return on equity-62.6%-156.6%
Analyst target vs. price+92.0%+101.0%
Analyst buy share36%100%
RSI (14)4154
30-day volatility77.8%61.9%
Max drawdown, 1 year-46.6%-46.9%
Trend readStrong downtrendLeaning bullish
Analyst consensusHoldBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • DMRA is the largest of the group by market value.
  • DMRA has returned the most over the past year.
  • DMRA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top